Department of Neuropathology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, Hirosaki 036-8562, Japan.
Neurosci Lett. 2012 Oct 3;527(1):16-21. doi: 10.1016/j.neulet.2012.08.035. Epub 2012 Aug 28.
Charged multivesicular body protein 2B (CHMP2B) is a component of the endosomal sorting complex required for transport-III, which is involved in the degradation of proteins in the endocytic and autophagic pathways. Mutations in the CHMP2B gene cause frontotemporal dementia and amyotrophic lateral sclerosis characterized by accumulation of ubiquitinated protein aggregates. Recent studies have shown that autophagosomal proteins are present in α-synuclein aggregates in neurons and glial cells in Parkinson's disease (PD), dementia with Lewy bodies (DLB) and multiple system atrophy (MSA). We therefore immunohistochemically examined the brains of various neurodegenerative diseases using CHMP2B-specific antibody. CHMP2B immunoreactivity was present in intracytoplasmic and axonal Lewy bodies in PD and DLB as well as in neuronal and glial cytoplasmic inclusions in MSA. No CHMP2B immunoreactivity was found in a variety of other neuronal and glial inclusions in TDP-43 proteinopathy and tauopathy. These findings suggest that endosomal and autophagic pathway is associated with degradation or formation of α-synuclein aggregates in α-synucleinopathy.
荷电多泡体蛋白 2B(CHMP2B)是内体分选复合物必需的组成部分,该复合物参与了内吞和自噬途径中蛋白质的降解。CHMP2B 基因突变可导致额颞叶痴呆和肌萎缩性侧索硬化症,其特征是泛素化蛋白聚集体的积累。最近的研究表明,自噬小体蛋白存在于帕金森病(PD)、路易体痴呆(DLB)和多系统萎缩(MSA)神经元和神经胶质细胞中的α-突触核蛋白聚集体中。因此,我们使用 CHMP2B 特异性抗体对各种神经退行性疾病的大脑进行了免疫组织化学检查。CHMP2B 免疫反应性存在于 PD 和 DLB 的细胞内和轴突Lewy 体中,以及 MSA 的神经元和神经胶质细胞质内包涵体中。在 TDP-43 蛋白病和tau 病的各种其他神经元和神经胶质包涵体中未发现 CHMP2B 免疫反应性。这些发现表明,内体和自噬途径与α-突触核蛋白病中α-突触核蛋白聚集体的降解或形成有关。